Literature DB >> 24680378

Haematological toxicity in adult patients receiving craniospinal irradiation--indication of a dose-bath effect.

Kristoffer Petersson1, Maria Gebre-Medhin2, Crister Ceberg3, Per Nilsson2, Per Engström4, Tommy Knöös4, Elisabeth Kjellén2.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to investigate the correlation between the haematological toxicity observed in patients treated with craniospinal irradiation, and the dose distribution in normal tissue, specifically the occurrence of large volumes exposed to low dose.
MATERIALS AND METHODS: Twenty adult male patients were included in this study; eight treated with helical tomotherapy (HT), and twelve with three-dimensional conformal radiation therapy. The relative volume of red bone marrow and body that was exposed to low dose (i.e. the so-called dose bath) was evaluated and correlated with nadir blood values during treatment, i.e. the severity of anaemia, leukopaenia, and thrombocytopaenia. The correlation was tested for different dose levels representing the dose bath using the Pearson product-moment correlation method.
RESULTS: We found a significant correlation between the volume of red bone marrow exposed to low dose and the severity of thrombocytopaenia during treatment. Furthermore, for the HT patients, a significant correlation was found between the relative volume of the body exposed to low dose and the severity of anaemia and leukopenia.
CONCLUSIONS: The severity of haematological toxicity correlated with the fraction of red bone marrow or body that was exposed to low dose.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Craniospinal irradiation; Dose bath; Haematological toxicity; Helical tomotherapy

Mesh:

Year:  2014        PMID: 24680378     DOI: 10.1016/j.radonc.2014.01.020

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Prospective study on dosimetric comparison of helical tomotherapy and 3DCRT for craniospinal irradiation - A single institution experience.

Authors:  Anna Bandurska-Luque; Tomasz Piotrowski; Agnieszka Skrobała; Adam Ryczkowski; Krystyna Adamska; Joanna Kaźmierska
Journal:  Rep Pract Oncol Radiother       Date:  2015-01-18

2.  A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future.

Authors:  L Maillie; L R Salgado; S Lazarev
Journal:  Clin Transl Oncol       Date:  2021-04-21       Impact factor: 3.405

3.  Evaluating the positional uncertainty of intrafraction, adjacent fields, and daily setup with the BrainLAB ExacTrac system in patients who are receiving craniospinal irradiation.

Authors:  Xiaojuan Duan; Yibing Zhou; Hongya Dai; Lirong Zhao; Jindong Qian; Dingqiang Yang; Liwei Zhang; Can Luo; Guanghui Li
Journal:  J Appl Clin Med Phys       Date:  2020-06-03       Impact factor: 2.102

4.  Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.

Authors:  Rami A El Shafie; Karina Böhm; Dorothea Weber; Kristin Lang; Fabian Schlaich; Sebastian Adeberg; Angela Paul; Matthias F Haefner; Sonja Katayama; Florian Sterzing; Juliane Hörner-Rieber; Sarah Löw; Klaus Herfarth; Jürgen Debus; Stefan Rieken; Denise Bernhardt
Journal:  Cancer Manag Res       Date:  2019-01-17       Impact factor: 3.989

5.  Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.

Authors:  I-Chia Liu; Adam L Holtzman; Ronny L Rotondo; Daniel J Indelicato; Sridharan Gururangan; Robert Cavaliere; Bridgette Carter; Christopher G Morris; Daryoush Tavanaiepour; Michael S Rutenberg
Journal:  J Neurooncol       Date:  2021-06-08       Impact factor: 4.130

6.  Case Report of Bone Marrow-Sparing Proton Therapy Craniospinal Irradiation for Central Nervous System Myelomatosis.

Authors:  Greg Kauffmann; Robin A Buerki; Rimas V Lukas; Vinai Gondi; Steven J Chmura
Journal:  Cureus       Date:  2017-11-28

7.  Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting.

Authors:  Michal Devecka; Marciana Nona Duma; Jan J Wilkens; Severin Kampfer; Kai Joachim Borm; Stefan Münch; Christoph Straube; Stephanie E Combs
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.